NDC 72237-101
XPOVIO
Selinexor
XPOVIO is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Karyopharm Therapeutics Inc.. The primary component is Selinexor.
| Product ID | 72237-101_08011ed7-91a4-4e4c-9185-d08ce3c0a448 |
| NDC | 72237-101 |
| Product Type | Human Prescription Drug |
| Proprietary Name | XPOVIO |
| Generic Name | Selinexor |
| Dosage Form | Tablet, Film Coated |
| Route of Administration | ORAL |
| Marketing Start Date | 2019-07-10 |
| Marketing Category | NDA / NDA |
| Application Number | NDA212306 |
| Labeler Name | Karyopharm Therapeutics Inc. |
| Substance Name | SELINEXOR |
| Active Ingredient Strength | 20 mg/1 |
| NDC Exclude Flag | N |
| Listing Certified Through | 2022-12-31 |
Packaging
NDC 72237-101-01
4 BLISTER PACK in 1 CARTON (72237-101-01) > 3 TABLET, FILM COATED in 1 BLISTER PACK (72237-101-11)
| Marketing Start Date | 2019-07-10 |
| NDC Exclude Flag | N |
| Sample Package? | N |
NDC SPL Data Element Entries
NDC 72237-101-05 [72237010105]
XPOVIO TABLET, FILM COATED
| Marketing Category | NDA |
| Application Number | NDA212306 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2019-07-10 |
NDC 72237-101-01 [72237010101]
XPOVIO TABLET, FILM COATED
| Marketing Category | NDA |
| Application Number | NDA212306 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2019-07-10 |
NDC 72237-101-11 [72237010111]
XPOVIO TABLET, FILM COATED
| Marketing Category | NDA |
| Application Number | NDA212306 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2019-07-10 |
NDC 72237-101-12 [72237010112]
XPOVIO TABLET, FILM COATED
| Marketing Category | NDA |
| Application Number | NDA212306 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2019-07-10 |
NDC 72237-101-02 [72237010102]
XPOVIO TABLET, FILM COATED
| Marketing Category | NDA |
| Application Number | NDA212306 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2019-07-10 |
NDC 72237-101-04 [72237010104]
XPOVIO TABLET, FILM COATED
| Marketing Category | NDA |
| Application Number | NDA212306 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2019-07-10 |
NDC 72237-101-15 [72237010115]
XPOVIO TABLET, FILM COATED
| Marketing Category | NDA |
| Application Number | NDA212306 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2019-07-10 |
NDC 72237-101-14 [72237010114]
XPOVIO TABLET, FILM COATED
| Marketing Category | NDA |
| Application Number | NDA212306 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2019-07-10 |
Drug Details
Active Ingredients
| Ingredient | Strength |
|---|---|
| SELINEXOR | 20 mg/1 |
NDC Crossover Matching brand name "XPOVIO" or generic name "Selinexor"
| NDC | Brand Name | Generic Name |
|---|---|---|
| 72237-101 | XPOVIO | selinexor |
| 72237-102 | XPOVIO | selinexor |
| 72237-103 | XPOVIO | selinexor |
| 72237-104 | XPOVIO | selinexor |
Trademark Results [XPOVIO]
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 XPOVIO 87719728 not registered Live/Pending |
Karyopharm Therapeutics Inc. 2017-12-13 |
 XPOVIO 86418181 not registered Dead/Abandoned |
Karyopharm Therapeutics Inc. 2014-10-08 |
© 2025 FDA.report
This site is not affiliated with or endorsed by the FDA.